[About the Issue of Organization of Primary Specialized Opthalmologic Care in Megalopolis].

The restriction of accessibility of primary specialized ophthalmologic medical care in polyclinics remains to be a main problem of its organization for population of large megalopolises. At that, similar medical services are actively provided by commercial optician's rooms. The purpose of study is to analyze perspectives of organization of primary specialized ophthalmologic medical sanitary care of population in large megalopolis. The questionnaire survey was carried out. The sampling included 4,248 patients of municipal polyclinics and 120 patients of ophthalmologic rooms of commercial opticians. The patients estimate higher accessibility of medical services in ophthalmologic rooms of commercial opticians as compared with municipal polyclinics (88.4% and 76% correspondingly). The most of patients (86%) argue in favor of receiving medical services in ophthalmologic rooms of commercial opticians at the expense of means of mandatory medical insurance. The sampling of 178 ophthalmologists of municipal polyclinics were included in survey concerning perspectives of involvement of ophthalmologic rooms of commercial opticians to provision of ophthalmologic services. This direction was supported by 28.4% of respondents. The article presents estimates of planning of volumes of medical care of patients being in need of optical correction of vision in case of its rendering by ophthalmologic rooms of commercial opticians in large megalopolis.

[Medical-genetic service and problems of prevention of hereditary diseases in the family]. / Mediko-geneticheskaia sluzhba i problemy profilaktiki nasledstvennoi patologii v sem'iakh.

The article provides the scientific substantiation of the economic effectiveness of early identification and treatment of patients with hereditary diseases proceeding from the example of patients suffering from mucoviscidosis. It was found that the degree of cost-effectiveness is closely related to the organization of early identification and timely treatment of such patients. The authors prove that identification and treatment of patients with mucoviscidosis is cost-effective.